Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Real-world Evaluation of Patient Outcomes and Experiences With Ribociclib Early Adopters.
A real-world study evaluating patient outcomes and experiences with ribociclib in breast cancer is currently recruiting, sponsored by Novart…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation [Phase 1]
NT-175 is being studied in a Phase 1 trial enrolling adults with unresectable, advanced, or metastatic solid tumors positive for HLA-A*02:01…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer [NA]
A clinical trial evaluating the comparative performance of Molecular Breast Imaging (MBI) versus Magnetic Resonance Imaging (MRI) for identi…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Multicomponent Prehabilitation in Older Adults With Breast Cancer [NA]
This entry notes a clinical trial recruiting older adults with breast cancer to test multicomponent prehabilitation. The study targets frail…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants [NA]
A study at MD Anderson Cancer Center is listed as active but not recruiting, evaluating a Diabetes Prevention Program with or without hunger…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer [Phase 1]
Phase 1 pilot study evaluating the clinical utility of Pylarify PET-CT for detecting metastasis in pancreatic cancer, hepatocellular carcino…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer [Phase 2]
Phase 2 clinical trial updates show BRC-001, a cannabidiol plant extract, being studied to improve aromatase inhibitor-induced arthralgia in…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Extended Sentinel Lymph Node Biopsy With Methylene Blue Single Tracer Post-Neoadjuvant Therapy for Node-Positive Breast Cancer [NA]
A clinical trial update describes evaluating extended sentinel lymph node biopsy using a single tracer, methylene blue, after neoadjuvant th…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer [Phase 2]
This Phase II randomized multicenter trial (SAPPHIRe-II) is evaluating shorter schedules of adjuvant regional nodal irradiation in breast ca…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Patient Relevant Outcomes Improvement Program in High Risk Hormone Receptor Positive (HR+) Breast Cancer
A clinical trial update describing a Patient Relevant Outcomes Improvement Program in high-risk HR-positive/HER2-negative early breast cance…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer
Clinical trial update describing an infertility survey for reproductive-age women with breast cancer and gynecologic cancers; the study is c…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer
A bidirectional cohort study to evaluate prophylactic resection surgery in individuals at moderate-to-high risk for hereditary ovarian cance…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Tumor-microenvironment Spatial Interaction to Identify Markers of Resistance to Therapy in HER2+ Breast Cancer Patients
This study aims to identify markers of resistance to therapy in HER2-positive breast cancer by analyzing tumor microenvironment spatial inte…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors [Phase 1]
This is a Phase 1 trial evaluating BGB-43395 alone or in combination for advanced breast cancer and other solid tumors. Recruitment is ongoi…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluates carboplatin and paclitaxel with or without panitumumab in invasive triple-negative breast cancer. The stu…
-
CLINICAL_TRIALS other · 2026-04-14Clinical Trial Update: Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer [Phase 3]
Phase 3 clinical trial update assessing saruparib (AZD5305) plus camizestrant versus a CDK4/6 inhibitor plus endocrine therapy or camizestra…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study. [Phase 2]
This is a Phase 2 exploratory neoadjuvant trial evaluating SHR-A1811 in combination with Pertuzumab for HER2-positive breast cancer; the stu…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer [Phase 4]
This clinical trial update discusses circulating microRNAs as biomarkers for hormone sensitivity in breast cancer. The Phase 4 study is comp…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer [Phase 3]
This clinical trial update reports a Phase 3 study evaluating regional radiotherapy in biomarker-low-risk node-positive and T3N0 breast canc…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of XMT-1660 in Participants With Solid Tumors [Phase 1]
Phase 1 study of XMT-1660 in participants with solid tumors is currently recruiting. The trial lists indications including triple-negative b…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
A National Cancer Institute trial is recruiting to collect blood from patients with various cancers for genetic analysis.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Harvesting Cells for Experimental Cancer Treatments
An NCI-sponsored clinical trial update indicates enrollment by invitation for a cell-harvesting approach in experimental cancer therapies ac…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Feasibility of 'Exercise for CAncer Patients and Healthy EAting Timeframes' . [NA]
The document outlines a feasibility study titled 'Exercise for Cancer Patients and Healthy Eating Timeframes' focused on breast cancer and c…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Ultra-Hypofractionated vs Moderate Hypofractionated Radiotherapy for Regional Lymph Nodes in High Risk Breast Cancer [NA]
A clinical trial compares ultra-hypofractionated versus moderate hypofractionated radiotherapy for regional lymph nodes in high-risk breast …
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Genomic Services Research Program
An NHGRI-sponsored genomic services research program is currently recruiting participants for studies in colon cancer and breast cancer.